Skip to content

Clinical trials

Phase 2 Inflammatory Bowel Diseases trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 2 Country / region: Romania Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20162
20171
20181
20201
20211
20221
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Terminated3
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2
Spyre Therapeutics, Inc.2
4SC AG1
Bristol-Myers Squibb1
GB004, Inc.1
Kyowa Kirin, Inc.1
Lakefront Biotherapeutics NV1
Palisade Bio1
Theravance Biopharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases14
Colitis, Ulcerative9
Crohn Disease6
Colitis5
Colonic Diseases2
Digestive System Diseases2
Gastrointestinal Diseases2
Intestinal Diseases2
Abdominal Pain1
Autoimmune Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.